06.01.2013 Views

Business Potential for Agricultural Biotechnology - Asian Productivity ...

Business Potential for Agricultural Biotechnology - Asian Productivity ...

Business Potential for Agricultural Biotechnology - Asian Productivity ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Business</strong> <strong>Potential</strong> <strong>for</strong> <strong>Agricultural</strong> <strong>Biotechnology</strong> Products in the Philippines<br />

Table 7. Price Ratios <strong>for</strong> Export Competitiveness by Variety (2000–01),<br />

Philippines<br />

Variety Export parity Domestic wholesale Price ratio*<br />

Non-GMO Solo 59.16 30 1.97<br />

GMO Solo 33.66 20 1.68<br />

Sinta 33.66 20 1.68<br />

*Price ratio = export parity price/domestic wholesale price; competitive if<br />

price ratio > 1<br />

Source: Laude, 2002<br />

As far as global cost-competitiveness, the ex ante domestic resource costs (DRCs) and<br />

resource cost ratios (RCRs) of Solo and Sinta papaya show possibilities of export competitiveness<br />

regardless of the presence or absence of the PRSV disease. For instance, the RCRs <strong>for</strong> both<br />

Solo GMO and non-GMO papaya regardless of yield group and port of export were less than one.<br />

This reveals the country’s competitive advantage in producing quality papaya <strong>for</strong> export. The<br />

Solo non-GMO papaya was more cost-competitive by 42% than the Solo GMO papaya (Table 8).<br />

Table 8. Ex ante Resource Cost Ratios (RCRs) of Solo and Sinta Papaya <strong>for</strong> Export by Port,<br />

by <strong>Biotechnology</strong> Delineation, and by Yield Group (2000–01), Southern Mindanao<br />

Low High<br />

Parameter<br />

Non-GMO a GMO b Non-GMO a GMO b<br />

Solo Papaya <strong>for</strong> export (Manila Port), Southern Tagalog<br />

DRC (P/HOUSD) 28.83 49.51 27.69 48.13<br />

RCR* 0.57 0.97 0.54 0.94<br />

Solo Papaya <strong>for</strong> export (Davao Port), Southern Mindanao<br />

DRC (PHP/USD) 24.50 41.85 23.36 40.46<br />

RCR* 0.48 0.82 0.46 0.79<br />

Sinta Papaya <strong>for</strong> export (Manila Port), Southern Tagalog c<br />

DRC (PHP/USD) 42.66 - 42.10 -<br />

RCR*<br />

a<br />

31.36% disease incidence<br />

b<br />

0% disease incidence<br />

c<br />

17.14% disease incidence<br />

0.84 - 0.83 -<br />

*Resource Cost Ratio (RCRs) was used as indicator of global competitiveness.<br />

RCR=DRC/OER; globally competitive if RCR < 1, neutral if RCR = 1, globally uncompetitive<br />

if RCR > 1; official exchange rate (OER) used was PHP51 = USD1.<br />

Source: Laude, 2002<br />

THE WAY FORWARD<br />

Challenges<br />

Successful adoption and commercialization of modern biotechnology products will depend<br />

on increased awareness by the general public of product benefits and safety and the market<br />

orientation of the key players from research to enterprise building, which will require special<br />

skills in technology management in general and market intelligence, market-led R&D, marketbased<br />

regulatory, market matching, and market retooling in particular. While the policy environment<br />

has been put in place through relevant laws and other policy instruments, the lack of<br />

limited expertise to successfully implement, monitor progress, and evaluate impact will remain a<br />

challenge. The current limited policy support on price, transport, microfinancing, and technical<br />

– 157 –

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!